NovaBridge Biosciences NBP
NASDAQ NBP
$1.34 -0.02 (-1.83%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Free Cash Flow (2019 - 2025)

Updated

NovaBridge Biosciences' Free Cash Flow was -$14.6 million in Q4 2025, compared with -$10.91 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Free Cash Flow (2019 - 2025) Analysis & Trends

For FY2025, Free Cash Flow at NovaBridge Biosciences came in at -$20.59 million.

  • In earlier years, Free Cash Flow was -$52.62 million in FY2024, -$183.05 million in FY2023, -$157.42 million in FY2022 and -$146.22 million in FY2021.
  • The Q4 2025 figure marks the lowest quarterly Free Cash Flow since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 NovaBridge Biosciences 150.88 Mn 150.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -14.60 Mn
Sep 30, 2025 1.84 Mn
Dec 31, 2024 -10.91 Mn
Sep 30, 2024 8.42 Mn
Dec 31, 2020 153.83 Mn
Sep 30, 2020 668,359.95
Dec 31, 2019 -29.56 Mn
API Access

NovaBridge Biosciences Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=NBP&period=max&api_key=YOUR_API_KEY